News & Insights Search

More than 500 comments have been submitted in response to the US Food and Drug Administration’s (FDA) discussion paper on generative AI (genAI)-enabled medical devices, and stakeholders have offered the agency a wide variety of advice on the best way to regulate these technologies.

BARCELONA – Navigating Europe’s complex environmental and sustainability legislation can be daunting, but healthcare product manufacturers can take concrete steps to ensure they remain compliant, according to two legal experts who spoke at RAPS Regulatory Intelligence Conference Europe on Tuesday.

Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.